Ozempic (Semaglutide for Diabetes)
brandedFDA-approved for type 2 diabetes. NOT approved for weight loss (off-label use only).
Est. Cost
$199-$349
Ozempic is the most recognized GLP-1 brand name, FDA-approved for type 2 diabetes management. While not FDA-approved for weight loss specifically, it is frequently prescribed off-label for that purpose. It contains semaglutide, the same active ingredient as Wegovy, but at a lower maximum dose (2mg vs 2.4mg). In 2026, Novo Nordisk introduced a self-pay offer starting at $199/month for the first two fills.
Dosage Format
Weekly subcutaneous injection — 0.25mg, 0.5mg, 1mg, or 2mg
Type
Branded
Who to discuss it with
Patients with type 2 diabetes who also want to manage weight
Key distinction
Same active ingredient as Wegovy but lower max dose (2mg vs 2.4mg) and different FDA indication
Where to Get Ozempic (Semaglutide for Diabetes)
Provider listings related to ozempic (semaglutide for diabetes). Confirm the exact formulation, current availability, and full price directly.
Ro
Available through Novo Nordisk self-pay program; $199/mo intro for first two fills
$199-$349/mo
How Ozempic (Semaglutide for Diabetes) Works
Ozempic works as a GLP-1 receptor agonist, mimicking the GLP-1 hormone to regulate blood sugar levels, slow gastric emptying, and reduce appetite. It activates receptors in the brain that help control hunger and food intake. While its primary FDA approval is for blood sugar management in type 2 diabetes, these appetite-reducing effects have made it widely used off-label for weight management.
Side Effects
Common
- • Nausea (especially during dose titration)
- • Diarrhea
- • Vomiting
- • Constipation
- • Abdominal pain
- • Injection site reactions
Serious risks and warning signs
- • Pancreatitis (rare)
- • Gallbladder problems
- • Thyroid tumors (risk seen in animal studies)
- • Kidney injury from dehydration due to GI side effects
Eligibility to Discuss With a Clinician
Ozempic is FDA-approved for adults with type 2 diabetes. For off-label weight loss use, providers may prescribe it based on clinical judgment, though insurance typically will not cover it for weight loss. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use Ozempic.
Related Medications
Provider Reviews
Explore providers in the weight loss category. This does not mean every provider offers Ozempic (Semaglutide for Diabetes); check the exact product with the provider.